PerpEquities

Equity

Cardinal Health, Inc. (CAH) perpetual futures

CAH perpetual futures on 1 crypto exchanges – live perp price vs the stock, funding rate, open interest and where to trade CAHUSDT.

Cardinal Health is a global healthcare services and products provider serving hospitals, pharmacies, clinics and patients through its Pharmaceutical and Medical divisions.

$250.29+3.3%NYSE open
Open in terminal

Price chart

Interactive TradingView chart

TradingView symbol NYSE:CAH

Loads TradingView's third-party widget (about 1 MB) on demand.

Auto: underlying reference priceOpen in TradingView

Trading data

Perpetual market activity

1/1 live markets
Venues
1
Live markets
1/1
24h volume
$16.8K
Open interest
$21.8K
Best liquidity
$64.9K
MEXC
Tightest spread
+13.2 bps
MEXC
Highest volume
$16.8K
MEXC
Settlement mix
USDT · 1/1
Perp/spot vol.
0.00x
Spot volume $493.6M
OI / float
0.00%
Float $57.8B
Spot performance
1D+3.35%
5D+4.18%
1M+6.49%
6M+16.95%
YTD+20.55%
1Y+59.14%

Venue matrix

1 markets

Some venue links are sponsored. We may receive a commission, and eligible users may occasionally receive trading-fee discounts, at no additional cost to you.

Trade
MEXCTradeCAH/USDTTrading$250.29-8.3% APR
-0.00760% every 8h
+13.2 bps$64.9K$16.8K$21.8KUSDT20x

Tradability

Execution quality

Entry cost and depth per venue at $1k–$100k

Thin liquidity · 1 of 1 venues absorb $10k · Typical cost: +29.5 bps

Cheapest execution: MEXC · +29.5 bps

Taker execution estimate incl. approx. fees - maker fills are not guaranteed.

Best venues for this underlying

Best liquidity

CAH

Tightest spread

CAH

Highest volume

CAH

Funding history

Stored venue snapshots by market

Company data

Company fundamentals

Updated 2h ago
Market cap
$57.4B
Updated 2h ago
Revenue
$254.2B
Trailing 12 months
Revenue growth
+5%
Next fiscal year
Profit margin
+0.7%
P/E
34.1
Peer P/E 23.5
Free cash flow
$4.5B
Trailing 12 months
More metrics
Net income
$1.7B
Trailing 12 months
P/S
0.2
Peer P/E
23.5
Similar listed perps
Revenue estimate
$265.8B
Next fiscal year
Earnings
2026-11-05
Revenue est. $66.6B · Updated 2h ago
Dividend
$0.516
2026-10-01

Fundamental detail

Annual + quarterly
Latest revenue$254.2B
Net margin+0.7%
Free cash flow$4.5B
Net debt$5.1B
2021$162.5B
2022$181.3B
2023$205B
2024$226.8B
2025$222.6B
2026$254.2B
PeriodRevenueGrowthNet incomeFCF
2021$162.5B+6%$611M$2B
2022$181.3B+12%-$938M$2.7B
2023$205B+13%$330M$2.4B
2024$226.8B+11%$852M$3.3B
2025$222.6B-2%$1.6B$1.9B
2026$254.2B+14%$1.7B$4.5B
PeriodGross marginOperating marginNet marginROEROA
2021+4.2%+0.3%+0.4%+34.1%+1.4%
2022+3.6%-0.3%-0.5%+132.3%-2.1%
2023+3.4%+0.4%+0.2%-11.2%+0.8%
2024+3.3%+0.5%+0.4%-26.5%+1.9%
2025+3.7%+1.0%+0.7%-56.1%+2.9%
2026+3.8%+1.0%+0.7%-59.5%+3.0%
PeriodCashDebtNet debtCurrent ratio
2021$3.4B$6.7B$3.3B1.12
2022$4.7B$5.8B$1.1B1.08
2023$4.1B$5.2B$1.1B1.00
2024$5.1B$5.6B$476M0.98
2025$3.9B$9.3B$5.5B0.94
2026$4.9B$9.9B$5.1B0.88
PeriodMarket capEnterprise valueP/SP/E
2021$16.7B$20B0.127.3
2022$14.6B$15.7B0.1-15.6
2023$24.7B$25.8B0.175.1
2024$24B$24.4B0.128.1
2025$40.5B$46B0.225.9
2026$56.1B$61.2B0.232.7
Q1 2025$52.3B
Q2 2025$55.3B
Q3 2025$54.9B
Q4 2025$60.2B
Q1 2026$64B
Q2 2026$65.4B
Q3 2026$60.9B
Q4 2026$63.9B
PeriodRevenueGrowthNet incomeFCF
Q1 2025$52.3B-4%$416M-$1.7B
Q2 2025$55.3B-4%$400M-$499M
Q3 2025$54.9B0%$506M$2.8B
Q4 2025$60.2B+1%$239M$1.3B
Q1 2026$64B+22%$450M$865M
Q2 2026$65.4B+18%$471M$555M
Q3 2026$60.9B+11%$399M$1.7B
Q4 2026$63.9B+6%$394M$1.4B
PeriodGross marginOperating marginNet marginROEROA
Q1 2025+3.6%+1.1%+0.8%-12.7%+1.0%
Q2 2025+3.5%+1.0%+0.7%-13.4%+0.9%
Q3 2025+3.9%+1.3%+0.9%-17.2%+1.0%
Q4 2025+3.7%+0.7%+0.4%-8.6%+0.4%
Q1 2026+3.6%+1.0%+0.7%-15.6%+0.8%
Q2 2026+3.4%+1.1%+0.7%-16.3%+0.8%
Q3 2026+4.1%+0.8%+0.7%-14.1%+0.7%
Q4 2026+4.3%+1.1%+0.6%-13.7%+0.7%
PeriodCashDebtNet debtCurrent ratio
Q1 2025$2.9B$5.2B$2.3B0.95
Q2 2025$3.8B$7.6B$3.8B1.02
Q3 2025$3.3B$7.7B$4.4B0.94
Q4 2025$3.9B$9.3B$5.5B0.94
Q1 2026$4.6B$9B$4.4B0.96
Q2 2026$2.8B$9B$6.3B0.91
Q3 2026$3.9B$8.9B$5B0.91
Q4 2026$4.9B$9.9B$5.1B0.88
PeriodMarket capEnterprise valueP/SP/E
Q1 2025$26.9B$29.2B0.516.2
Q2 2025$28.6B$32.4B0.517.9
Q3 2025$33.1B$37.4B0.616.3
Q4 2025$40.2B$45.6B0.742.0
Q1 2026$37.4B$41.8B0.620.8
Q2 2026$48.5B$54.7B0.725.9
Q3 2026$49.7B$54.6B0.831.3
Q4 2026$56.1B$61.2B0.934.7

Refreshed 2h ago

Charts: revenue, profit, cash flow & valuation
Revenue$63.9BQ4 2026
$16.4B$32.7B$49.1B$65.4BQ1 2024: $54.7BQ2 2024: $57.4BQ3 2024: $54.9BQ4 2024: $59.7BQ1 2025: $52.3BQ2 2025: $55.3BQ3 2025: $54.9BQ4 2025: $60.2BQ1 2026: $64BQ2 2026: $65.4BQ3 2026: $60.9BQ4 2026: $63.9BQ1 2024Q4 2026
Net income$394MQ4 2026
$117.5M$247M$376.5M$506MQ1 2024: -$12MQ2 2024: $368MQ3 2024: $261MQ4 2024: $236MQ1 2025: $416MQ2 2025: $400MQ3 2025: $506MQ4 2025: $239MQ1 2026: $450MQ2 2026: $471MQ3 2026: $399MQ4 2026: $394MQ1 2024Q4 2026
EBITDA$1.1BQ4 2026
$262.5M$525M$787.5M$1.1BQ1 2024: $139MQ2 2024: $690MQ3 2024: $547MQ4 2024: $578MQ1 2025: $755MQ2 2025: $738MQ3 2025: $946MQ4 2025: $667MQ1 2026: $911MQ2 2026: $776MQ3 2026: $741MQ4 2026: $1.1BQ1 2024Q4 2026
Free cash flow$1.4BQ4 2026
-$605M$527M$1.7B$2.8BQ1 2024: $436MQ2 2024: $1.1BQ3 2024: -$139MQ4 2024: $1.9BQ1 2025: -$1.7BQ2 2025: -$499MQ3 2025: $2.8BQ4 2025: $1.3BQ1 2026: $865MQ2 2026: $555MQ3 2026: $1.7BQ4 2026: $1.4BQ1 2024Q4 2026
EPS$1.69Q4 2026
$0.49$1.03$1.56$2.1Q1 2024: -$0.05Q2 2024: $1.5Q3 2024: $1.07Q4 2024: $0.96Q1 2025: $1.7Q2 2025: $1.65Q3 2025: $2.1Q4 2025: $1Q1 2026: $1.88Q2 2026: $1.97Q3 2026: $1.69Q4 2026: $1.69Q1 2024Q4 2026
Cash / Debt$4.9BQ4 2026
$2.5B$5B$7.5B$9.9BQ1 2024 · Cash: $3.9BQ1 2024 · Debt: $4.7BQ2 2024 · Cash: $4.6BQ2 2024 · Debt: $4.7BQ3 2024 · Cash: $3.7BQ3 2024 · Debt: $5.9BQ4 2024 · Cash: $5.1BQ4 2024 · Debt: $5.6BQ1 2025 · Cash: $2.9BQ1 2025 · Debt: $5.2BQ2 2025 · Cash: $3.8BQ2 2025 · Debt: $7.6BQ3 2025 · Cash: $3.3BQ3 2025 · Debt: $7.7BQ4 2025 · Cash: $3.9BQ4 2025 · Debt: $9.3BQ1 2026 · Cash: $4.6BQ1 2026 · Debt: $9BQ2 2026 · Cash: $2.8BQ2 2026 · Debt: $9BQ3 2026 · Cash: $3.9BQ3 2026 · Debt: $8.9BQ4 2026 · Cash: $4.9BQ4 2026 · Debt: $9.9BQ1 2024Q4 2026
CashDebt
Profitability+4.3%Q4 2026
+1.0%+2.1%+3.2%+4.3%Q1 2024 · Gross margin: +3.2%Q2 2024 · Gross margin: +3.2%Q3 2024 · Gross margin: +3.5%Q4 2024 · Gross margin: +3.1%Q1 2025 · Gross margin: +3.6%Q2 2025 · Gross margin: +3.5%Q3 2025 · Gross margin: +3.9%Q4 2025 · Gross margin: +3.7%Q1 2026 · Gross margin: +3.6%Q2 2026 · Gross margin: +3.4%Q3 2026 · Gross margin: +4.1%Q4 2026 · Gross margin: +4.3%Q1 2024 · Operating margin: -0.1%Q2 2024 · Operating margin: +0.9%Q3 2024 · Operating margin: +0.7%Q4 2024 · Operating margin: +0.7%Q1 2025 · Operating margin: +1.1%Q2 2025 · Operating margin: +1.0%Q3 2025 · Operating margin: +1.3%Q4 2025 · Operating margin: +0.7%Q1 2026 · Operating margin: +1.0%Q2 2026 · Operating margin: +1.1%Q3 2026 · Operating margin: +0.8%Q4 2026 · Operating margin: +1.1%Q1 2024 · Net margin: 0.0%Q2 2024 · Net margin: +0.6%Q3 2024 · Net margin: +0.5%Q4 2024 · Net margin: +0.4%Q1 2025 · Net margin: +0.8%Q2 2025 · Net margin: +0.7%Q3 2025 · Net margin: +0.9%Q4 2025 · Net margin: +0.4%Q1 2026 · Net margin: +0.7%Q2 2026 · Net margin: +0.7%Q3 2026 · Net margin: +0.7%Q4 2026 · Net margin: +0.6%Q1 2024Q4 2026
Gross marginOperating marginNet margin
Revenue growth+6.1%Q4 2026
+2.4%+9.0%+15.7%+22.4%Q1 2025: -4.3%Q2 2025: -3.8%Q3 2025: 0.0%Q4 2025: +0.8%Q1 2026: +22.4%Q2 2026: +18.4%Q3 2026: +11.0%Q4 2026: +6.1%Q1 2024Q4 2026
Shares outstanding237MQ4 2026
62.5M125M187.5M250MQ1 2024: 250MQ2 2024: 246MQ3 2024: 245MQ4 2024: 245MQ1 2025: 245MQ2 2025: 243MQ3 2025: 241MQ4 2025: 240MQ1 2026: 239MQ2 2026: 237MQ3 2026: 236MQ4 2026: 237MQ1 2024Q4 2026
Valuation34.7Q4 2026
-315.1-196.0-77.042.0Q1 2024 · P/E: -434.1Q2 2024 · P/E: 16.8Q3 2024 · P/E: 26.2Q4 2024 · P/E: 25.5Q1 2025 · P/E: 16.2Q2 2025 · P/E: 17.9Q3 2025 · P/E: 16.3Q4 2025 · P/E: 42.0Q1 2026 · P/E: 20.8Q2 2026 · P/E: 25.9Q3 2026 · P/E: 31.3Q4 2026 · P/E: 34.7Q1 2024 · P/S: 0.4Q2 2024 · P/S: 0.4Q3 2024 · P/S: 0.5Q4 2024 · P/S: 0.4Q1 2025 · P/S: 0.5Q2 2025 · P/S: 0.5Q3 2025 · P/S: 0.6Q4 2025 · P/S: 0.7Q1 2026 · P/S: 0.6Q2 2026 · P/S: 0.7Q3 2026 · P/S: 0.8Q4 2026 · P/S: 0.9Q1 2024Q4 2026
P/EP/S
Revenue$254.2B2026
$63.6B$127.1B$190.7B$254.2B2019: $145.5B2020: $152.9B2021: $162.5B2022: $181.3B2023: $205B2024: $226.8B2025: $222.6B2026: $254.2B20192026
Net income$1.7B2026
-$2.3B-$989.5M$362.3M$1.7B2019: $1.4B2020: -$3.7B2021: $611M2022: -$938M2023: $330M2024: $852M2025: $1.6B2026: $1.7B20192026
EBITDA$3.5B2026
-$1.1B$428.5M$2B$3.5B2019: $3B2020: -$2.6B2021: $1.3B2022: $55M2023: $1.4B2024: $2B2025: $3.1B2026: $3.5B20192026
Free cash flow$4.5B2026
$1.1B$2.3B$3.4B$4.5B2019: $2.4B2020: $1.6B2021: $2B2022: $2.7B2023: $2.4B2024: $3.3B2025: $1.9B2026: $4.5B20192026
EPS$7.232026
-$7.64-$2.69$2.27$7.232019: $4.532020: -$12.62021: $2.082022: -$3.342023: $1.262024: $3.452025: $6.452026: $7.2320192026
Cash / Debt$4.9B2026
$2.5B$5B$7.5B$9.9B2019 · Cash: $2.5B2019 · Debt: $8B2020 · Cash: $2.8B2020 · Debt: $6.8B2021 · Cash: $3.4B2021 · Debt: $6.7B2022 · Cash: $4.7B2022 · Debt: $5.8B2023 · Cash: $4.1B2023 · Debt: $5.2B2024 · Cash: $5.1B2024 · Debt: $5.6B2025 · Cash: $3.9B2025 · Debt: $9.3B2026 · Cash: $4.9B2026 · Debt: $9.9B20192026
CashDebt
Profitability+3.8%2026
-0.8%+1.0%+2.9%+4.7%2019 · Gross margin: +4.7%2020 · Gross margin: +4.5%2021 · Gross margin: +4.2%2022 · Gross margin: +3.6%2023 · Gross margin: +3.4%2024 · Gross margin: +3.3%2025 · Gross margin: +3.7%2026 · Gross margin: +3.8%2019 · Operating margin: +1.4%2020 · Operating margin: -2.7%2021 · Operating margin: +0.3%2022 · Operating margin: -0.3%2023 · Operating margin: +0.4%2024 · Operating margin: +0.5%2025 · Operating margin: +1.0%2026 · Operating margin: +1.0%2019 · Net margin: +0.9%2020 · Net margin: -2.4%2021 · Net margin: +0.4%2022 · Net margin: -0.5%2023 · Net margin: +0.2%2024 · Net margin: +0.4%2025 · Net margin: +0.7%2026 · Net margin: +0.7%20192026
Gross marginOperating marginNet margin
Revenue growth+14.2%2026
+2.2%+6.2%+10.2%+14.2%2020: +5.1%2021: +6.2%2022: +11.6%2023: +13.0%2024: +10.7%2025: -1.9%2026: +14.2%20192026
Shares outstanding237M2026
75.3M150.5M225.8M301M2019: 301M2020: 293M2021: 294M2022: 279M2023: 262M2024: 247M2025: 242M2026: 237M20192026
Valuation32.72026
7.029.752.475.12019 · P/E: 10.52020 · P/E: -4.12021 · P/E: 27.32022 · P/E: -15.62023 · P/E: 75.12024 · P/E: 28.12025 · P/E: 25.92026 · P/E: 32.72019 · P/S: 0.12020 · P/S: 0.12021 · P/S: 0.12022 · P/S: 0.12023 · P/S: 0.12024 · P/S: 0.12025 · P/S: 0.22026 · P/S: 0.220192026
P/EP/S

Next catalyst

Catalysts

Earnings
2026-11-05
Revenue est. $66.6B · Updated 2h ago
Dividend
$0.516
2026-10-01

No unusual perp activity right now.

Research data

Analysts, filings and peer context

Estimates

6
DateEPS estimateRevenue estimateGrowthAnalysts
FY 202712.54$265.8B+5%10
FY 202814.07$281.7B+11%9
FY 202915.59$297.4B+17%4
FY 203017.81$306.5B+21%1
FY 203120.43$314.2B+24%2
Q3 20283.68$72.1B+18%5

Company events

6
2026-11-05EarningsActual - / Estimate 2.95-
2026-10-01Dividend$0.516-
2026-08-11EarningsActual 2.91 / Estimate 2.42Beat
2026-07-01Dividend$0.516-
2026-04-30EarningsActual 3.17 / Estimate 2.79Beat
2026-04-01Dividend$0.511-

Peer comparison

Similar listed perps

Analyst track record

How the analysts covering CAH have done: ratings, price-target accuracy and the measured reaction after their calls.

12 months3 years
Ratings79251
Analysts2024
Buy / hold / sell69 / 10 / 0169 / 73 / 9
Upgrades / downgrades / initiations1 / 0 / 48 / 0 / 8
Price targets hit / missed34 / 38 (47%)201 / 38 (84%)
Avg. return after a rating (TipRanks)+1.0%+62.6%
Best / worst call+35.4% / -15.2%+163.6% / -15.2%

After buy calls on this stock: median 21-day move +2.1% vs S&P 500 +0.8% (n = 170)

Most accurate on this stock

Share of an analyst's price targets on this stock that the price reached within 12 months (our measurement over the last 3 years, at least 8 targets). It describes past calls, not the odds of the current one.

  1. Michael ChernyLeerink Partners100% hit rate on this stock · 16 targets measuredBuytarget $292Aug 11, 2026
  2. Erin WrightMorgan Stanley100% hit rate on this stock · 14 targets measuredBuytarget $255Aug 12, 2026
  3. Kevin CaliendoUBS100% hit rate on this stock · 8 targets measuredBuytarget $274Jul 20, 2026

Latest ratings

DateAnalystCallTarget
Oct 6, 2026Ryan HalstedRBC CapitalBuyMaintained$276
Sep 9, 2026Stephen BaxterWells FargoBuyMaintained$277
Aug 18, 2026Glen SantangeloBarclaysBuyReiterated$275
Aug 19, 2026Ryan HalstedRBC CapitalBuyInitiated$276
Aug 17, 2026Lisa GillJ.P. MorganHoldMaintained$260

TipRanks data via FMP · computed Oct 15, 2026 · 79 ratings

Frequently asked questions

Where can I trade CAH perpetual futures?

Cardinal Health, Inc. (CAH) perpetual futures trade on 1 crypto venues, including MEXC. PerpEquities compares them by live price, funding rate, open interest and liquidity.

Can I trade CAH around the clock?

Yes. Unlike the underlying stock, CAH perpetuals trade 24/7 — including weekends and outside regular market hours.

What is the funding rate on CAH perpetuals?

Right now the CAH perp funding rate is -8.3% annualized (venue median), ranging from -8.3% to -8.3% across 1 venues. A positive rate means longs pay shorts. PerpEquities shows the live rate and its history for every venue.

How does the CAH perp price compare to the Cardinal Health, Inc. stock?

The venue-median CAH perp mark is $250.3 versus a reference stock price of $250.3, a basis of 0.0%. Perps follow the stock through an index price; the gap widens when funding or liquidity diverge between venues.

What is a CAH perpetual future?

A CAH perpetual is a derivative that tracks the price of Cardinal Health, Inc. with no expiry date. It lets you take long or short exposure to Cardinal Health, Inc. on crypto venues, around the clock.

What is CAHUSDT perpetual?

CAHUSDT is the symbol most crypto exchanges use for the Cardinal Health, Inc. perpetual settled in USDT (Tether). It tracks the CAH share price through an index, trades 24/7 with leverage and never expires.

Embed this asset

CAH perpetuals · perpequities.comCAH perpetuals · perpequities.com
<a href="https://perpequities.com/stocks/cah-perp"><img src="https://perpequities.com/badge/cah-perp.svg" width="240" height="64" alt="CAH perpetuals · perpequities.com" loading="lazy"></a>

Next step

Stay on top of CAH perps

Signals with a track record

Analysts who hit 70%+ of their targets on the perps we track, congress buys over $500k, 13F positions over $5M, funding spreads that have paid for days. Every post shows the evidence. Free, no sign-up.

Join on Telegram

Weekly digest by email

The listings, funding and moves that matter for CAH — one email every Sunday.

Watchlist and alerts

Price and funding alerts for CAH, via push or Telegram.

Set an alert

Follow the live feed

Daily movers, new listings and funding extremes as they happen.

Follow on X